SERPINI2

gene
On this page

Also known as TSA2004MEPI

Summary

SERPINI2 (serpin family I member 2, HGNC:8945) is a protein-coding gene on chromosome 3q26.1, encoding Serpin I2 (O75830).

The gene encodes a member of a family of proteins that acts as inhibitors of serine proteases. These proteins function in the regulation of a variety of physiological processes, including coagulation, fibrinolysis, development, malignancy, and inflammation. Expression of the encoded protein may be downregulated during pancreatic carcinogenesis. Alternative splicing results in multiple transcript variants for this gene.

Source: NCBI Gene 5276 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 54 total
  • MANE Select transcript: NM_006217

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:8945
Approved symbolSERPINI2
Nameserpin family I member 2
Location3q26.1
Locus typegene with protein product
StatusApproved
AliasesTSA2004, MEPI
Ensembl geneENSG00000114204
Ensembl biotypeprotein_coding
OMIM605587
Entrez5276

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 6 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000264677, ENST00000461846, ENST00000465031, ENST00000466903, ENST00000467583, ENST00000471111, ENST00000476257, ENST00000495108

RefSeq mRNA: 3 — MANE Select: NM_006217 NM_001012303, NM_001394327, NM_006217

CCDS: CCDS3200

Canonical transcript exons

ENST00000264677 — 9 exons

ExonStartEnd
ENSE00000780136167446392167446481
ENSE00000780137167449316167449402
ENSE00000780138167452936167453033
ENSE00000780139167465206167465398
ENSE00000780140167465479167465673
ENSE00000780141167467055167467285
ENSE00000826118167441933167442185
ENSE00001831569167474003167474042
ENSE00003635048167471588167471844

Expression profiles

Bgee: expression breadth ubiquitous, 175 present calls, max score 99.54.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4531 / max 512.6483, expressed in 3 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
454480.45313

Top tissues by expression

286 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
body of pancreasUBERON:000115099.54gold quality
pancreasUBERON:000126493.59gold quality
right uterine tubeUBERON:000130291.64gold quality
bronchial epithelial cellCL:000232887.81gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.94gold quality
islet of LangerhansUBERON:000000685.32gold quality
epithelium of bronchusUBERON:000203185.26gold quality
bronchusUBERON:000218583.70gold quality
olfactory segment of nasal mucosaUBERON:000538680.62gold quality
epithelial cell of pancreasCL:000008377.27gold quality
mucosa of paranasal sinusUBERON:000503075.13silver quality
monocyteCL:000057672.79gold quality
mononuclear cellCL:000084272.35gold quality
caudate nucleusUBERON:000187371.15gold quality
choroid plexus epitheliumUBERON:000391171.11silver quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099170.75gold quality
leukocyteCL:000073870.51gold quality
nucleus accumbensUBERON:000188269.87gold quality
oviduct epitheliumUBERON:000480469.85gold quality
fallopian tubeUBERON:000388969.80gold quality
ventricular zoneUBERON:000305366.33gold quality
corpus callosumUBERON:000233666.19gold quality
right lungUBERON:000216766.02gold quality
right atrium auricular regionUBERON:000663165.72gold quality
hypothalamusUBERON:000189865.23gold quality
amygdalaUBERON:000187665.15gold quality
diaphragmUBERON:000110365.03gold quality
cardiac atriumUBERON:000208164.36gold quality
granulocyteCL:000009463.54gold quality
olfactory bulbUBERON:000226462.70gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-81547yes29.00
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

21 targeting SERPINI2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-590-3P99.9674.346478
HSA-MIR-1211999.8768.351653
HSA-MIR-5002-5P99.7670.841763
HSA-MIR-64199.7569.351975
HSA-MIR-3617-5P99.7569.411968
HSA-MIR-5580-3P99.7069.412052
HSA-MIR-4677-5P99.7070.091940
HSA-MIR-6715B-5P99.6469.631420
HSA-MIR-7156-5P99.6468.811369
HSA-MIR-426199.5970.303415
HSA-MIR-4649-3P99.5666.901783
HSA-MIR-426999.5569.891373
HSA-MIR-1212399.5271.792990
HSA-MIR-147B-5P99.4570.622432
HSA-MIR-329-5P99.2768.111597
HSA-MIR-6739-3P99.2268.841843
HSA-MIR-570198.9769.541502
HSA-MIR-397696.6767.791187
HSA-MIR-4790-3P96.6367.08806
HSA-MIR-4524B-3P95.5264.12964
HSA-MIR-574-3P92.3564.2741

Literature-anchored findings (GeneRIF, showing 1)

  • The findings indicate that SERPINI2 is a promising candidate for further investigations of the genetic susceptibility to myopia. (PMID:22110064)

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusSerpini2ENSMUSG00000034139
rattus_norvegicusSerpini2ENSRNOG00000009903

Paralogs (36): SERPINB1 (ENSG00000021355), SERPINB3 (ENSG00000057149), SERPIND1 (ENSG00000099937), SERPINA4 (ENSG00000100665), SERPINE1 (ENSG00000106366), SERPINC1 (ENSG00000117601), SERPINA7 (ENSG00000123561), SERPINB6 (ENSG00000124570), SERPINF1 (ENSG00000132386), AGT (ENSG00000135744), SERPINE2 (ENSG00000135919), SERPINA10 (ENSG00000140093), SERPING1 (ENSG00000149131), SERPINH1 (ENSG00000149257), SERPINI1 (ENSG00000163536), SERPINA12 (ENSG00000165953), SERPINB7 (ENSG00000166396), SERPINB8 (ENSG00000166401), SERPINB12 (ENSG00000166634), SERPINF2 (ENSG00000167711), SERPINA9 (ENSG00000170054), SERPINA6 (ENSG00000170099), SERPINB9 (ENSG00000170542), SERPINA11 (ENSG00000186910), SERPINA5 (ENSG00000188488), SERPINA3 (ENSG00000196136), SERPINA1 (ENSG00000197249), SERPINB2 (ENSG00000197632), SERPINB13 (ENSG00000197641), SERPINB11 (ENSG00000206072), SERPINB4 (ENSG00000206073), SERPINB5 (ENSG00000206075), HMSD (ENSG00000221887), SERPINB10 (ENSG00000242550), SERPINE3 (ENSG00000253309), SERPINA2 (ENSG00000258597)

Protein

Protein identifiers

Serpin I2O75830 (reviewed: O75830)

Alternative names: Myoepithelium-derived serine protease inhibitor, Pancpin, Pancreas-specific protein TSA2004, Peptidase inhibitor 14

All UniProt accessions (4): A0A8V8PL11, C9J7N5, C9JWE1, O75830

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Secreted.

Tissue specificity. Expressed in pancreas and adipose tissues.

Similarity. Belongs to the serpin family.

RefSeq proteins (3): NP_001012303, NP_001381256, NP_006208* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000215Serpin_famFamily
IPR023795Serpin_CSConserved_site
IPR023796Serpin_domDomain
IPR036186Serpin_sfHomologous_superfamily
IPR042178Serpin_sf_1Homologous_superfamily
IPR042185Serpin_sf_2Homologous_superfamily

Pfam: PF00079

UniProt features (8 total): glycosylation site 3, sequence variant 2, signal peptide 1, chain 1, site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O75830-F186.300.70

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 357–358 (reactive bond)

Glycosylation sites (3): 202, 207, 306

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 72 (showing top): WU_APOPTOSIS_BY_CDKN1A_VIA_TP53, chr3q26, BLALOCK_ALZHEIMERS_DISEASE_UP, MODULE_99, SCHLOSSER_SERUM_RESPONSE_DN, RYTTCCTG_ETS2_B, FOXJ2_02, TGGAAA_NFAT_Q4_01, GOMF_PEPTIDASE_REGULATOR_ACTIVITY, WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN, GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY, GOMF_ENZYME_INHIBITOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, YOSHIMURA_MAPK8_TARGETS_UP, WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP

GO Biological Process (0):

GO Molecular Function (3): serine-type endopeptidase inhibitor activity (GO:0004867), protein binding (GO:0005515), peptidase inhibitor activity (GO:0030414)

GO Cellular Component (3): obsolete extracellular space (GO:0005615), extracellular exosome (GO:0070062), extracellular region (GO:0005576)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
serine-type endopeptidase activity1
endopeptidase inhibitor activity1
binding1
enzyme inhibitor activity1
peptidase activity1
peptidase regulator activity1
extracellular vesicle1
cellular anatomical structure1

Protein interactions and networks

STRING

370 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SERPINI2PI15O43692694
SERPINI2PI16Q6UXB8670
SERPINI2CPB1P15086654
SERPINI2PLATP00750585
SERPINI2RPE65Q16518583
SERPINI2PLAUP00749521
SERPINI2WDR49Q8IV35514
SERPINI2PLGP00747507
SERPINI2PLA2G1BP04054506
SERPINI2ZBBXA8MT70450
SERPINI2CEP290O15078432
SERPINI2ARFGEF3Q5TH69389
SERPINI2FAM124AQ86V42389
SERPINI2ZNF80P51504374
SERPINI2ADAM18Q9Y3Q7348
SERPINI2PNLIPRP1P54315348

IntAct

33 interactions, top by confidence:

ABTypeScore
UBQLN1SERPINI2psi-mi:“MI:0915”(physical association)0.900
SERPINI2UBQLN1psi-mi:“MI:0915”(physical association)0.900
SERPINI2SGTBpsi-mi:“MI:0915”(physical association)0.670
UBQLN1SERPINI2psi-mi:“MI:0915”(physical association)0.560
SERPINI2UBQLN1psi-mi:“MI:0915”(physical association)0.560
SGTASERPINI2psi-mi:“MI:0915”(physical association)0.560
SERPINI2UBQLN2psi-mi:“MI:0915”(physical association)0.560
SERPINI2HPCAL1psi-mi:“MI:0915”(physical association)0.560
SERPINI2NUP58psi-mi:“MI:0915”(physical association)0.400
SERPINI2H2BC9psi-mi:“MI:0915”(physical association)0.400
BAG6SERPINI2psi-mi:“MI:0915”(physical association)0.370
PRKCEPRPSAP2psi-mi:“MI:0914”(association)0.350
SERPINI2LEPRpsi-mi:“MI:0914”(association)0.350
SERPINI2UBQLN1psi-mi:“MI:0915”(physical association)0.000
SERPINI2SGTBpsi-mi:“MI:0915”(physical association)0.000
SERPINI2SGTApsi-mi:“MI:0915”(physical association)0.000
SERPINI2UBQLN2psi-mi:“MI:0915”(physical association)0.000
SERPINI2HPCAL1psi-mi:“MI:0915”(physical association)0.000

BioGRID (20): UBQLN1 (Two-hybrid), UBQLN1 (Two-hybrid), SERPINI2 (Biochemical Activity), SERPINI2 (Two-hybrid), SGTB (Two-hybrid), BAG6 (Two-hybrid), SERPINI2 (Two-hybrid), HPCAL1 (Two-hybrid), UBQLN1 (Two-hybrid), UBQLN2 (Two-hybrid), SGTB (Two-hybrid), SERPINI2 (Affinity Capture-MS), HIST1H2BH (Proximity Label-MS), NUPL1 (Proximity Label-MS), SNIP1 (Affinity Capture-MS)

ESM2 similar proteins: A2I7N3, B0UYL8, O75830, P01015, P01017, P01019, P05121, P05154, P05155, P05544, P05545, P05546, P07759, P09006, P11859, P13909, P20757, P20961, P22777, P29622, P31211, P32759, P47776, P49182, P50448, P50449, P70458, P79335, P97290, Q03734, Q5I2A0, Q5RCR2, Q5RDA8, Q60396, Q62975, Q63556, Q64268, Q6P4P1, Q6P734, Q7TMF5

Diamond homologs: A0A090BX51, A0A0K8RCY5, A0A0K8RJ89, A0A0K8RJV9, A5PJK0, A9RA96, B0CMB0, B1MTB7, B1MTC3, B2KI30, B3RFC3, B4USX2, E2RVI8, O02739, O08800, O35684, O54757, O54758, O54759, O54760, O73790, O73860, O75635, O75830, P01008, P01011, P01012, P01014, P05120, P05619, P12388, P17475, P19104, P22323, P22325, P22922, P23035, P29508, P29524, P30740

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

54 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance42
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2070 predictions. Top by Δscore:

VariantEffectΔscore
3:167442186:C:CCacceptor_gain1.0000
3:167465227:T:TAdonor_gain1.0000
3:167467054:CCAT:Cdonor_gain1.0000
3:167467084:A:ACdonor_gain1.0000
3:167467084:AT:Adonor_gain1.0000
3:167467084:ATCAT:Adonor_gain1.0000
3:167467085:T:Cdonor_gain1.0000
3:167467147:T:TAdonor_gain1.0000
3:167442181:TGATT:Tacceptor_gain0.9900
3:167442183:ATTC:Aacceptor_loss0.9900
3:167442184:TT:Tacceptor_gain0.9900
3:167442184:TTCTA:Tacceptor_loss0.9900
3:167442185:TC:Tacceptor_loss0.9900
3:167442186:C:Aacceptor_loss0.9900
3:167442187:T:Aacceptor_loss0.9900
3:167449237:A:ACdonor_gain0.9900
3:167449238:C:CCdonor_gain0.9900
3:167449240:T:TAdonor_gain0.9900
3:167450648:A:Cdonor_gain0.9900
3:167465228:C:Adonor_gain0.9900
3:167467067:TTTC:Tdonor_gain0.9900
3:167467068:TTCT:Tdonor_gain0.9900
3:167467070:C:CTdonor_gain0.9900
3:167467071:T:TTdonor_gain0.9900
3:167467241:C:CCacceptor_gain0.9900
3:167473845:CATT:Cacceptor_gain0.9900
3:167442182:GATT:Gacceptor_gain0.9800
3:167442183:ATT:Aacceptor_gain0.9800
3:167449124:T:TAdonor_gain0.9800
3:167465201:CCAA:Cdonor_loss0.9800

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000039759 (3:167461265 C>T), RS1000087923 (3:167460817 A>T), RS1000148186 (3:167454714 C>G), RS1000212167 (3:167467680 T>C), RS1000303592 (3:167450600 A>G), RS1000443903 (3:167475678 T>C), RS1000675637 (3:167452027 T>C), RS1000871670 (3:167456409 A>G), RS1000912836 (3:167444141 G>A), RS1000983032 (3:167476898 T>A), RS1000996932 (3:167462541 G>T), RS1001015416 (3:167444856 A>C), RS1001248205 (3:167477103 T>C), RS1001261842 (3:167478139 G>A), RS1001424351 (3:167455733 C>G)

Disease associations

OMIM: gene MIM:605587 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST004048_1Fast beta electroencephalogram5.000000e-09
GCST009391_575Metabolite levels7.000000e-06
GCST009391_633Metabolite levels3.000000e-06
GCST010135_19Oily fish consumption3.000000e-10
GCST010136_12Fruit consumption1.000000e-08
GCST010140_11Pork consumption3.000000e-10
GCST010142_12Fish- and plant-related diet1.000000e-11
GCST012489_93Heel bone mineral density x serum urate levels interaction8.000000e-09

EFO canonical traits (6, from GWAS)

EFO IDTrait name
EFO:0004357electroencephalogram measurement
EFO:0021604hypoxanthine measurement
EFO:0010503inosine measurement
EFO:0008111diet measurement
EFO:0004531urate measurement
EFO:0009270heel bone mineral density

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

10 total (human), top 10 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases methylation1
sodium arseniteaffects methylation1
vanadyl sulfateincreases expression1
2-amino-3,8-dimethylimidazo(4,5-f)quinoxalinedecreases expression1
S-(1,2-dichlorovinyl)cysteineincreases expression, affects cotreatment, affects response to substance1
bisphenol Sdecreases methylation1
Lipopolysaccharidesaffects response to substance, increases expression, affects cotreatment1
Tobacco Smoke Pollutiondecreases expression1
Aflatoxin B1decreases methylation1
Antirheumatic Agentsdecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.